Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma.

[1]  A. Wein,et al.  Campbell-Walsh Urology , 2011 .

[2]  M. Lai,et al.  A Novel Cancer Therapy by Skin Delivery of Indoleamine 2,3-Dioxygenase siRNA , 2009, Clinical Cancer Research.

[3]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. , 2008, European urology.

[4]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[5]  H. Chiou,et al.  Inducible nitric oxide synthase promoter polymorphism, cigarette smoking, and urothelial carcinoma risk. , 2007, Urology.

[6]  V. Reuter,et al.  CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma , 2007, Proceedings of the National Academy of Sciences.

[7]  W. Weninger.  Visualizing intratumoral immune responses , 2007 .

[8]  P. Sharma,et al.  Focus on TILs: Prognosticsignificance of tumor infiltrating lymphocytes in human bladdercancer , 2007 .

[9]  H. Ohtani.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. , 2007 .

[10]  T. Tzai,et al.  Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model. , 2006, Cancer research.

[11]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[12]  H. Ozen,et al.  The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. , 2006, The Journal of urology.

[13]  J Alfred Witjes,et al.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.

[14]  Yi Luo,et al.  Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand , 2004, Cancer Research.

[15]  Gerhard Jakse,et al.  A second-look TUR in T1 transitional cell carcinoma: why? , 2004, European urology.

[16]  Y. Shiue,et al.  The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract , 2003, Cancer.

[17]  M. Grimm,et al.  Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. , 2003, The Journal of urology.

[18]  M. Peyromaure,et al.  The value of a second transurethral resection in evaluating patients with bladder tumours. , 2003, European urology.

[19]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[20]  Laurence Collette,et al.  Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. , 2002, European urology.

[21]  Jin-Hwang Liu,et al.  Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. , 2002, Urology.

[22]  H Nagura,et al.  Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. , 2001, Cancer research.

[23]  P. Schlag,et al.  Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. , 2001, Cancer research.

[24]  G. Jakse,et al.  Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? , 2001, The Journal of urology.

[25]  Y. Chou,et al.  Unusual clinical presentation of upper urothelial carcinoma in Taiwan , 1999, Cancer.

[26]  Y. H. Lee,et al.  Uraemia with concomitant urothelial cancer. , 1993, British journal of urology.

[27]  K. Jauhiainen,et al.  Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. , 1992, European journal of cancer.

[28]  M. Álvarez-Mon,et al.  Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder. , 1990, The Journal of urology.

[29]  T. Akiyama,et al.  Immunocompetence of tissue infiltrating lymphocytes in bladder tumors. , 1988, The Journal of urology.

[30]  M. GonzálezMartín,et al.  Urothelial tumors of the upper urinary tract , 1985 .

[31]  Petkovic Sd.  Treatment of bilateral renal pelvic and ureteral tumors. A review of 45 cases. , 1978 .

[32]  J. Menzoian,et al.  Immunologic unreactivity in bladder cancer patients. , 1972, The Journal of urology.